Paul J. Milligan

机构：Program for Appropriate Technology in Health, London School of Hygiene & Tropical Medicine · ORCID：0000-0003-3430-3395

发表论文 402 篇 · 总被引 21653 次 · h-index 71

代表论文

Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case–control studies in 5 countries (2021 · PLoS Medicine · 被引 104)
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi (2024 · The Lancet · 被引 89)
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial (2023 · The Lancet Infectious Diseases · 被引 72)
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study (2022 · The Lancet Infectious Diseases · 被引 72)
Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach (2023 · Malaria Journal · 被引 46)
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone (2022 · BMC Medicine · 被引 36)